AzTrials
AzTrials

Anesthesia, SpinalCesARNCT04719819

Spinal Anaesthesia for Caesarean Section: Descriptive Multicentre Study

An observational study of Anesthesia, Spinal and Nonemergency Cesarean Section, run by University Hospital, Clermont-Ferrand at 11 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Most of caesarean sections can be performed under spinal anaesthesia. Its major advantages are reliability and fast onset. However, dose of hyperbaric bupivacaine used, combination with adjuvants, hemodynamic management, and impact of these measures on maternal experience are not uniform. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Spinal anaesthesia for caesarean section
Type of treatment
Surgery or procedure
How many people
600 participants
Where
11 sitesFrance
Study dates
31 Jan 2021to 3 Feb 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Women with spinal anaesthesia scheduled or non-emergency caesarean section

Who may be able to join

  • Age ≥ 18 years old
  • Affiliation to social security system
  • Scheduled or elective Caesarean section (green code) under spinal anesthesia

Who cannot join

  • Refusal to participate in the study
  • Code red Caesarean section or general anesthesia decision
  • Complicated" Caesarean section or combined spinal-epidural technique
  • Presence of an epidural catheter
  • Performing a combined spinal-epidural technique (even if the epidural catheter is not used)
  • Contraindication to spinal anaesthesia (coagulation disorder, vertebral-medullary pathologies)
  • Patient under guardianship or curatorship

Trial locations and contacts

11 sites in 1 country.

11 sites in 1 country

France11 sites
  • CHU

    Clermont-Ferrand

  • CHU

    Grenoble

  • Hôpital Emile Roux

    Le Puy-en-Velay

  • CHU

    Lille

  • HCL

    Lyon

  • CHU

    Nancy

  • CHU

    Nîmes

  • APHP Cochin

    Paris

  • APHP Necker

    Paris

  • APHP Trousseau

    Paris

  • Hôpital Jacques Puel

    Rodez

Other trials in France

About this study

Most of caesarean sections can be performed under spinal anaesthesia. Its major advantages are reliability and fast onset. However, dose of hyperbaric bupivacaine used, combination with adjuvants, hemodynamic management, and impact of these measures on maternal experience are not uniform. This study aims to describe practices of spinal anaesthesia for caesarean section in France to improve practices, guide new studies and establish protocols.

Read the detailed description

Most of caesarean sections can be performed under spinal anaesthesia. Its major advantages are reliability and fast onset. However, techniques of spinal anaesthesia are varied. Dose of hyperbaric bupivacaine used may shifted, varying intensity of sensor block but also hemodynamic side effect. Likewise, use of adjuvant is frequent and differs between centres. Management of the maternal hemodynamic is also discussed. While it is recognized that intraoperatively vascular filling alone is not effective, use of vasopressors is not unequivocal. For example, recent studies support the use of norepinephrine.

Finally, maternal experience is a hot topic. Although insufficient anaesthesia is rare, it is often overlooked. There are few recommendations on the intraoperative treatment of insufficient anaesthesia and to the management of post-traumatic stress that it lead to.

The objective of this study is to describe practices of spinal anaesthesia for scheduled or non-emergency caesarean section (also named "green code") in France by detailing several points:

Technique of spinal anaesthesia:

  • The anaesthesia solution used (doses and adjuvants)
  • Management of hemodynamic
  • Management of insufficient anaesthesia
  • Maternal experience It aims to make an inventory of practices, to orient future studies, guide practice and the realization of protocols.

It is an observational study unfolds from 2021 to 2022. It concerns 11 French centres and 600 women. Data are collected with an online questionnaire.

Being tested
Spinal anaesthesia for caesarean section
Keywords
Anaesthesia, Spinal, Caesarean Section, Hyperbaric bupivacaine, Hemodynamic management after spinal anaesthesia, Maternal experience

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal anaesthesia for caesarean sectionProcedure or surgery

    Descriptive questionnaire with open and closed questions, to be completed during the procedure

Study groups in NCT04719819
Study groupRoleWhat they receive
Usual praticeAssessment of usual practices
Receives: Procedure: Spinal anaesthesia for caesarean section

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal data

    Ad hoc Questionnaire

    Measured: Day of surgery

  2. Obstetrical data

    Ad hoc Questionnaire

    Measured: Day of surgery

  3. Spinal procedure

    Ad hoc Questionnaire

    Measured: Day of surgery

  4. Haemodynamic management

    Ad hoc Questionnaire

    Measured: Day of surgery

  5. Maternal experience

    Ad hoc Questionnaire

    Measured: Day of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2021
  2. Study start31 Jan 2021
  3. Primary completion20 Dec 2022
  4. Study completion3 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04719819
Sponsor's protocol ID
RNI 2020 BONNIN
Acronym
CesAR
Status last verified
Feb 2023
First submitted
18 Jan 2021
Last updated
8 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia, Spinal and Nonemergency Cesarean Section, run by University Hospital, Clermont-Ferrand at 11 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal data (time frame: Day of surgery). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in